Brazil must “run after lost time” (Valli, Russo & Bolzani
2018), which is also a reality for the entire subcontinent.
Latin America enters this race with a disadvantage: between 1981
and 2014, in the pharmaceutical market 1,211 new products were
introduced, of which 60 % were obtained from natural substances
or were designed from structures found in nature (Newman &
Cragg 2016).